cuprous oxide 0.4 MG
RxNorm concept 891809, clinical drug component (scdc).
- RxCUI
- 891809
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/891809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ascorbic acid 113 MG / beta carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / zinc oxide 17.4 MG Oral Tablet (SCD, constitutes)
- ascorbic acid 113 MG / beta carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / zinc oxide 17.4 MG Oral Tablet [PreserVision] (SBD, constitutes)
- cuprous oxide (IN, has ingredient)
- ascorbic acid 113 MG / beta carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / zinc oxide 17.4 MG [PreserVision] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 891809 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/891809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 891809. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.